Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime-avibactam and metronidazole in pediatric complicated intra-abdominal infections
NCT02475733Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2015
- Primary completion
- Jun 2017
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 10
01
Overview
A Phase 2 trial of ceftazidime + avibactam in Intra-abdominal infection (IAI), sponsored by Pfizer. Started Aug 2015; status: completed.
02
Drugs
ceftazidime + avibactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT02475733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02475733.